- Back to menuPrices
- Back to menuResearch
- Back to menuConsensus
- Back to menu
- Back to menu
- Back to menu
- Back to menuWebinars & Events
Latest from Ian Allison
R3 Taps Software Sales Vet to 'Evangelize' Paid Version of Corda
R3 has hired software sales pro Cathy Minter as chief revenue officer to grow the user base for its paid DLT product, Corda Enterprise.

40-Strong Blockchain Insurance Group B3i Appoints CEO
Insurance industry blockchain group B3i has appointed John Carolin as chief executive officer.

Coinbase Is in Talks to Launch Its Own Insurance Company
Coinbase is exploring plans to set up its own regulated insurance company with the help of broker Aon, sources told CoinDesk.

Ex-R3 Exec's New Mission: Run $100 Trillion Fund Trade on Private Blockchains
Former R3 executive Brian McNulty has launched a blockchain startup aiming to streamline fund management.

IBM-Maersk Shipping Blockchain Gains Steam With 15 Carriers Now on Board
IBM has recruited two more major shipping carriers to join the blockchain platform it owns with container giant Maersk.

Ethereum Tokens to Trade on Swiss Stock Exchange via R3 Tech
Swiss stock exchange SIX's digital asset platform will list "mirrored" versions of ethereum tokens using R3's tech.

Buried in Facebook's Libra White Paper, a Digital Identity Bombshell
Buried in Facebook’s Libra white paper are two sentences hinting the project's ambitions go even further than minting a global currency.

Facebook's Libra Cryptocurrency: A Technical Deep Dive
Technical details of Facebook's Libra blockchain were published Tuesday in a white paper by the Libra Foundation. Here's what stands out.

Private Blockchain's Biggest Startups Integrate in Unprecedented Tie-Up
A historic change in strategy is taking place at R3 and Digital Asset (DA), who are now collaborating to maximize their respective blockchain ecosystems.

Retail Giant Walmart Enters Second Drug-Tracking Blockchain Trial
Walmart will take part in a second drug-tracking blockchain pilot, this one with IBM, KPMG and drug maker Merck.
